These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 3103576)
21. Muscle carnitine deficiency presenting as familial fatal cardiomyopathy. Colin AA; Jaffe M; Shapira Y; Ne'eman Z; Gutman A; Korman S Arch Dis Child; 1987 Nov; 62(11):1170-2. PubMed ID: 3688923 [TBL] [Abstract][Full Text] [Related]
22. [Congestive cardiomyopathy in infancy: pathogenetic role of carnitine and selenium deficiency (author's transl)]. Squarcia U; Sellitto F Pediatr Med Chir; 1981; 3(6):473-6. PubMed ID: 7045826 [No Abstract] [Full Text] [Related]
23. Exclusive cardiac dysfunction in familial primary carnitine deficiency cases: a genotype-phenotype correlation. Yamak A; Bitar F; Karam P; Nemer G Clin Genet; 2007 Jul; 72(1):59-62. PubMed ID: 17594400 [No Abstract] [Full Text] [Related]
24. Review: Metabolic cardiomyopathy and conduction system defects in children. Gilbert-Barness E Ann Clin Lab Sci; 2004; 34(1):15-34. PubMed ID: 15038665 [TBL] [Abstract][Full Text] [Related]
25. Primary systemic carnitine deficiency: a Turkish case with a novel homozygous SLC22A5 mutation and 14 years follow-up. Yilmaz BS; Kor D; Mungan NO; Erdem S; Ceylaner S J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1179-81. PubMed ID: 26030785 [TBL] [Abstract][Full Text] [Related]
26. Cardiac involvement in Fukuyama-type congenital muscular dystrophy. Nakanishi T; Sakauchi M; Kaneda Y; Tomimatsu H; Saito K; Nakazawa M; Osawa M Pediatrics; 2006 Jun; 117(6):e1187-92. PubMed ID: 16717122 [TBL] [Abstract][Full Text] [Related]
27. [Carnitine deficiency myopathy: a case of late diagnosis]. Rico Corral MA; de la Vega Vázquez JM; Holgado Silva C; Aznar Martín A; Zamora Madaría E An Med Interna; 2002 Aug; 19(8):415-8. PubMed ID: 12244790 [TBL] [Abstract][Full Text] [Related]
28. Primary carnitine deficiency cardiomyopathy. Wang SS; Rao J; Li YF; Zhang ZW; Zeng GH Int J Cardiol; 2014 Jun; 174(1):171-3. PubMed ID: 24746540 [No Abstract] [Full Text] [Related]
29. Cardiac manifestations in disorders of fat and carnitine metabolism in infancy. Ino T; Sherwood WG; Benson LN; Wilson GJ; Freedom RM; Rowe RD J Am Coll Cardiol; 1988 Jun; 11(6):1301-8. PubMed ID: 3367006 [TBL] [Abstract][Full Text] [Related]
30. Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy. Campos Y; Huertas R; Lorenzo G; Bautista J; Gutiérrez E; Aparicio M; Alesso L; Arenas J Muscle Nerve; 1993 Feb; 16(2):150-3. PubMed ID: 8429838 [TBL] [Abstract][Full Text] [Related]
31. [Tachycardia-induced cardiomyopathy, unusual and reversible cause of left ventricular dysfunction: report of 9 cases]. Quiniou G; Chevalier JM; Barbou F; Bire F; Clémenty J Ann Cardiol Angeiol (Paris); 2000 Aug; 49(5):301-8. PubMed ID: 12555514 [TBL] [Abstract][Full Text] [Related]
32. [A cause of dilated cardiomyopathy in a child: primary carnitine deficiency]. Baragou S; Pio M; Di Bernardo S; Ksontini TB; Dommange SJ; Bonafe L; Meijboom E; Sekarski N Ann Cardiol Angeiol (Paris); 2014 Apr; 63(2):107-10. PubMed ID: 22260907 [TBL] [Abstract][Full Text] [Related]
33. [Metabolic and genetic investigations in childhood cardiomyopathies]. Bonnet D; Rustin P; Rötig A; de Lonlay P; Viot G; Munnich A; Sidi D Arch Mal Coeur Vaiss; 1999 Nov; 92(11):1509-14. PubMed ID: 10598230 [TBL] [Abstract][Full Text] [Related]
34. [Reliability and limitation of various diagnostic methods including nuclear medicine in myocardial disease (author's transl)]. Tokuyasu Y; Kusakabe K; Yamazaki T; Tazaki E; Sekiguchi M; Hiroe M; Morimoto S; Fujioka T; Nakamura K; Hirosawa K J Cardiogr; 1981 Dec; 11(4):1113-25. PubMed ID: 7201492 [TBL] [Abstract][Full Text] [Related]
35. Thirty-year follow-up of carnitine supplementation in two siblings with hypertrophic cardiomyopathy caused by primary systemic carnitine deficiency. Kishimoto S; Suda K; Yoshimoto H; Teramachi Y; Nishino H; Koteda Y; Itoh S; Kudo Y; Iemura M; Matsuishi T Int J Cardiol; 2012 Aug; 159(1):e14-5. PubMed ID: 22154200 [No Abstract] [Full Text] [Related]
36. [Clinical polymorphic presentation and natural history of active myocarditis: experience in 60 cases]. Sinagra G; Maras P; D'Ambrosio A; Gregori D; Bussani R; Silvestri F; Morgera T; Pinamonti B; Salvi A; Alberti E; Di Lenarda A; Lardieri G; Klugmann S; Camerini F G Ital Cardiol; 1997 Aug; 27(8):758-74. PubMed ID: 9312504 [TBL] [Abstract][Full Text] [Related]
38. End-stage cardiac disease as an initial presentation of systemic myopathies: case series and literature review. Katzberg H; Karamchandani J; So YT; Vogel H; Wang CH J Child Neurol; 2010 Nov; 25(11):1382-8. PubMed ID: 20445193 [TBL] [Abstract][Full Text] [Related]
39. Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy. Helton E; Darragh R; Francis P; Fricker FJ; Jue K; Koch G; Mair D; Pierpont ME; Prochazka JV; Linn LS; Winter SC Pediatrics; 2000 Jun; 105(6):1260-70. PubMed ID: 10835067 [TBL] [Abstract][Full Text] [Related]
40. Ventricular fibrillation without overt cardiomyopathy as first presentation of organic cation transporter 2-deficiency in adolescence. Rijlaarsdam RS; van Spronsen FJ; Bink-Boelkens MT; Reijngoud DJ; Wanders RJ; Niezen-Koning KE; Van der Sluijs FH; Dorland B; Beaufort-Krol GC Pacing Clin Electrophysiol; 2004 May; 27(5):675-6. PubMed ID: 15125729 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]